Rid­ing on coat­tails of Comir­naty suc­cess, BioN­Tech wins mR­NA man­u­fac­tur­ing con­tract with Ger­man gov­ern­ment

Ger­man biotech and wild­ly suc­cess­ful Pfiz­er part­ner, BioN­Tech, has notched its next con­tract on home turf, cour­tesy of the Ger­man gov­ern­ment.

The biotech, who part­nered with Pfiz­er on the de­vel­op­ment of megablock­buster Covid-19 vac­cine Comir­naty, said in a brief state­ment ear­li­er to­day that it had been grant­ed a pan­dem­ic pre­pared­ness con­tract from the fed­er­al gov­ern­ment’s de­part­ment of health — to man­u­fac­ture and sup­ply mR­NA vac­cines for emer­gency sit­u­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER